Kristen Focht, MBA
- 3Articles
- 14.9KReads
- 2013–2014Active
- 18Collaborators
- 195Citations
About
Kristen Focht, MBA, has published research on major depressive disorder (MDD), focusing on the treatment efficacy and safety of desvenlafaxine in various populations, including perimenopausal and postmenopausal women. Her work also explores genetic factors related to depression treatment, such as cytochrome P450 2D6 phenoconversion and its implications for personalized medicine. Her articles appeared in Psychiatrist.com between 2013 and 2014.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
